Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing, China.
Cancer Control. 2023 Jan-Dec;30:10732748231180745. doi: 10.1177/10732748231180745.
There are few clinical symptoms in early colorectal cancer, so it is necessary to find a simple and economical tumor detection index for auxiliary diagnosis. This study aims to explore the diagnostic value of preoperative inflammation-related indicators, such as neutrophil, lymphocyte, platelet count, platelet to lymphocyte ratio (PLA), neutrophil to lymphocyte ratio (NLR), and systemic immune-inflammation index (SII), for early colorectal cancer, and determine whether inflammation-related indicators can provide more accurate diagnostic judgment for patients.
This study was a retrospective study. Patients who were first diagnosed with colorectal cancer or colorectal adenomatous polyp at Beijing Friendship Hospital from October 2016 to October 2017 were retrospectively collected. According to inclusion and exclusion criteria, a total of 342 patients were included, including 216 patients with colorectal cancer and 126 patients with colorectal adenomatous polyp. Fasting venous blood and other clinical features were collected to compare the differences between colorectal cancer and colorectal adenoma.
There were statistically significant differences in age, carcinoembryonic antigen, albumin, hemoglobin, mean platelet volume, lymphocyte, monocyte, NLR, PLA, SII, and mean platelet volume to platelet count ratio between colorectal cancer group and colorectal adenoma group ( < .05), and a Nomogram model was established. Using inflammatory markers to differentiate colorectal and colorectal polyps produced greater AUC than using tumor markers alone (.846 vs .695).
Inflammation-related indicators, such as lymphocyte, monocyte, and mean platelet volume, may serve as potential indicators to assist in the diagnosis of early colorectal cancer.
早期结直肠癌临床症状较少,因此有必要寻找一种简单、经济的肿瘤检测指标进行辅助诊断。本研究旨在探讨术前炎症相关指标(如中性粒细胞、淋巴细胞、血小板计数、血小板与淋巴细胞比值、中性粒细胞与淋巴细胞比值和全身免疫炎症指数)对早期结直肠癌的诊断价值,并确定炎症相关指标是否能为患者提供更准确的诊断判断。
本研究为回顾性研究。收集 2016 年 10 月至 2017 年 10 月期间在北京友谊医院首次诊断为结直肠癌或结直肠腺瘤性息肉的患者。根据纳入和排除标准,共纳入 342 例患者,其中 216 例为结直肠癌患者,126 例为结直肠腺瘤性息肉患者。采集空腹静脉血及其他临床特征,比较结直肠癌与结直肠腺瘤之间的差异。
结直肠癌组与结直肠腺瘤组在年龄、癌胚抗原、白蛋白、血红蛋白、平均血小板体积、淋巴细胞、单核细胞、中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值、全身免疫炎症指数和平均血小板体积与血小板计数比值方面差异均有统计学意义(<0.05),并建立了列线图模型。使用炎症标志物对结直肠和结直肠息肉进行区分产生的 AUC 大于单独使用肿瘤标志物(0.846 比 0.695)。
淋巴细胞、单核细胞和平均血小板体积等炎症相关指标可能成为辅助诊断早期结直肠癌的潜在指标。